Â鶹ÊÓƵ

It focuses on niche products and high-growth markets and doesn't bring the R&D risk of larger pharma stocks

The data and training provider is reaping the rewards of investments it made during the pandemic

Mining ‘tourists’ have backed off this month, making it a good time to buy into this diversified major

Having turned its back on huge acquisitions, this life insurer plans to settle down and pay out high dividends

Billions of dollars of stock-based compensation could hit free cash flow in the near future

This multi-asset investment trust could prove a bargain if you like private assets, dividends and steady growth

The manufacturer is seen as a bargain but even a 30 per cent share price slide this year isn't enough given the scale of the problems

It has been a poor investment in recent years, but its strikingly low valuation presents an opportunity

With great prospects, a market-leading position and solid cash margins, it's clear to see why private equity is interested in this tech stock

The potential of the FTSE 250 contractor is being picked up by stock screens, but not by investors